3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia
19
Leukemia, Promyelocytic, Acute
11
Multiple Myeloma
8
Leukemia, Myeloid, Acute
7
Myelodysplastic Syndromes
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms, Plasma Cell
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Eosinophilic, Acute
3
Leukemia, Basophilic, Acute
3
Central Nervous System Neoplasms
3
Burkitt Lymphoma
3
Blast Crisis
3
Testicular Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
HhAntag691
18
Imiquimod
10
sonidegib
8
Photochemotherapy
7
1-phenyl-3,3-dimethyltriazene
6
methyl 5-aminolevulinate
4
Surgical Procedures, Operative
4
Biopsy
4
Aminolevulinic Acid
4
cemiplimab
3
Mohs Surgery
3
Microscopy, Confocal
3
Itraconazole
3
IPI-926
3
3-ingenyl angelate
3
tazarotene
2
Microarray Analysis
2
Laser Therapy
2
Gene Expression Profiling
2
Eflornithine
2
Drug Evaluation
2
Acitretin
2
tozuleristide
1
teriflunomide
1
talimogene laherparepvec
1
silmitasertib
1
remetinostat
1
pembrolizumab
1
gusacitinib
1
green tea extract polyphenone E
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Basal Cell
×
Arsenic Trioxide
×
Clear all
NCT01791894
2018-06-08
ATO
Stanford University
Phase 1/2
Completed
5 enrolled
9 charts